Get the latest Science News and Discoveries
PolyU collaborates with Axis Therapeutics to establish joint laboratory for immunotherapy - EurekAlert
The Hong Kong Polytechnic University (PolyU) has entered into a formal collaboration with Axis Therapeutics (Axis) to foster cancer immunotherapy research and development, with the aim of improving cancer treatment for patients in Hong Kong. This collaboration will facilitate clinical trials of new T-cell receptor therapy using the newly established clinical Current Good Manufacturing Practice (cGMP) facility at PolyU, which is compliant with the GMP Guide for the Advanced Therapy Products (ATPs), and the development of at least 30 new targeting agents against novel T-cell targets in cancer immunotherapy.
None
Or read this on Eureka Alert